Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Hypertension Reports
Metadata
Title
The role of angiotensin II in regulating vascular structural and functional changes in hypertension
Author
Rhian M. Touyz, MD, PhD
Publication date
01-04-2003
Publisher
Current Medicine Group
Published in
Current Hypertension Reports / Issue 2/2003
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-003-0073-2

Other articles of this Issue 2/2003

Current Hypertension Reports 2/2003 Go to the issue

Abstract

Literature alert

OriginalPaper

Insulin resistance in HIV-related lipodystrophy

OriginalPaper

The effect of aldosterone on glucose metabolism

OriginalPaper

Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology

Invited Commentary

Vascular abnormalities in salt-sensitive hypertension

OriginalPaper

Aldosterone and specific aldosterone receptor antagonists in hypertension and cardiovascular disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits